The people
behind Indivi
The people
behind Indivi
Indivi is a neuroscience measurement company headquartered in Basel, Switzerland, with offices in Córdoba, Spain and Boston, Massachusetts. We combine precision measurement, advanced analytics, and scientific expertise to help biopharmaceutical sponsors design smaller early-phase trials and detect treatment effects with greater confidence.
Our multimodal platform currently includes smartphone-based motor and cognitive assessments. Our work spans Parkinson’s disease, neuromuscular diseases including facioscapulohumeral muscular dystrophy (FSHD), multiple sclerosis, and Alzheimer’s disease and related dementias.
Indivi is a neuroscience measurement company headquartered in Basel, Switzerland, with offices in Córdoba, Spain and Boston, Massachusetts. We combine precision measurement, advanced analytics, and scientific expertise to help biopharmaceutical sponsors design smaller early-phase trials and detect treatment effects with greater confidence.
Our multimodal platform currently includes smartphone-based motor and cognitive assessments. Our work spans Parkinson’s disease, neuromuscular diseases including facioscapulohumeral muscular dystrophy (FSHD), multiple sclerosis, and Alzheimer’s disease and related dementias.
Indivi is a neuroscience measurement company headquartered in Basel, Switzerland, with offices in Córdoba, Spain and Boston, Massachusetts. We combine precision measurement, advanced analytics, and scientific expertise to help biopharmaceutical sponsors design smaller early-phase trials and detect treatment effects with greater confidence.
Our multimodal platform currently includes smartphone-based motor and cognitive assessments. Our work spans Parkinson’s disease, neuromuscular diseases including facioscapulohumeral muscular dystrophy (FSHD), multiple sclerosis, and Alzheimer’s disease and related dementias.
Our Leadership Team
Our Leadership Team
Our Leadership Team
Guilhem Dupont
Guilhem Dupont
Chairman, CEO
Chairman, CEO
The founder and commercial leader of Indivi, Guilhem has over 12 years of experience in global leadership roles at Johnson & Johnson and Roche. Guilhem is passionate about improving the lives of those affected by chronic conditions
The founder and commercial leader of Indivi, Guilhem has over 12 years of experience in global leadership roles at Johnson & Johnson and Roche. Guilhem is passionate about improving the lives of those affected by chronic conditions
Corne de Jong
Corne de Jong
CFO
CFO
Corne is an expert in processes and IT through working with organisations including Johnson & Johnson, Baxter International, UCB and GSK Pharma. Corne has led the Operations and Client Program Management at Indivi since 2016
Corne is an expert in processes and IT through working with organisations including Johnson & Johnson, Baxter International, UCB and GSK Pharma. Corne has led the Operations and Client Program Management at Indivi since 2016
Simone Rey
Simone Rey
COO
COO
Simone is a passionate, results-driven pharmaceutical leader with over 20 years of experience across medical affairs, clinical operations, program and alliance management. She has shaped high-performing, collaborative teams and driven impactful results at companies like MSD, Biogen, Roche and Neurimmune.
Simone is a passionate, results-driven pharmaceutical leader with over 20 years of experience across medical affairs, clinical operations, program and alliance management. She has shaped high-performing, collaborative teams and driven impactful results at companies like MSD, Biogen, Roche and Neurimmune.
Shibeshih Mitiku Belachew
Shibeshih Mitiku Belachew
CMO
CMO
MD PhD, Neurologist and Neuroscientist with over 12 years of scientific leadership impact at Biogen and F. Hoffmann-La Roche
MD PhD, Neurologist and Neuroscientist with over 12 years of scientific leadership impact at Biogen and F. Hoffmann-La Roche
James R. Williams
James R. Williams
CBO
CBO
James leads Indivi’s corporate strategy and commercial growth while overseeing U.S. operations. He holds a PhD from Johns Hopkins and brings 16 years of experience at the FDA, Biogen, and venture-backed startups, spanning 20+ drug, device, and diagnostic programs in neuroscience and rare disease.
James leads Indivi’s corporate strategy and commercial growth while overseeing U.S. operations. He holds a PhD from Johns Hopkins and brings 16 years of experience at the FDA, Biogen, and venture-backed startups, spanning 20+ drug, device, and diagnostic programs in neuroscience and rare disease.
